Search | Syneos Health Communications

#1

Check out this EMG GOLD Podcast where Ian Dorrian, President Communications Europe at Syneos Health, shares his journey from pharmaceutical to the agency world, and touches upon topics including the impact of virtual communications on future product launches.

#2

In this podcast our team discusses the digital therapeutics landscape, the opportunities for both biopharma and tech companies, regulatory and payer hurdles, and more.

#3

Check out this installment of The MM&M Podcast with Kathleen Starr, PhD, Managing Director, Behavioral Science and Insights at Syneos Health.

#4

Listen to our podcast with Jessica Shull, European Lead for the Digital Therapeutics Alliance, an international non-profit trade association of industry leaders and stakeholders engaged in the evidence-driven advancement of digital therapeutics.

#5

Jeanine O'Kane, President of the Public Relations Group at inVentiv Health speaks to PRWeek editor-in-chief Steve Barrett and news editor Frank Washkuch in this podcast.

#6

Check out this PharmaVOICE WoW (Woman Of The Week) podcast, where Maria Tender, Head of Strategy - Communications at Syneos Health, describes how she unleashes talent to make health communications stand out.

#7

Host Jeff Stewart talks with Kathleen Starr, Managing Director of the Behavioral Insights group at INC Research/inVentiv Health.

#8

Catch Meg Alexander, Head, Reputation & Risk Management Practice at Syneos Health, on RARECast - a podcast focused on the intersection of rare disease with business, science, and policy.

#9

A commercial model built to deliver blockbuster drugs to the market is no longer effective – particularly for delivering therapies for complex disease states to smaller, more targeted patient populations and specialty providers.

#10

In this podcast, Amy Hutnik, our Chief Growth and Transformation Officer, talks about how communications intelligence and channels have advanced with the availability of data.

#11

This podcast discusses the importance of collaboration between the Medical Affairs and Market Access functions in developing a consistent and clear medical narrative.

#12

Pharmaceutical leaders are meeting customers in their AirPods, according to iHeartMedia President Conal Byrne, because audio is a newly critical space for American content consumption.

#13

Listen to this Syneos Health podcast for the factors impacting this shift, and what it all means for developers, healthcare providers, and patients.

#14

The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.

#15

It’s just one word.

#16

This article from FiercePharma talks about the release of 2019 Health Trend Ten eBook by Syneos Health, which outlines critical shifts impacting drug development and commercialization.

#17

Caregivers are an integral part of care teams and are involved in everything from medication choices to adherence strategies.

#18

Patient advocacy has evolved over time, and with it, patient advocate archetypes have emerged.

#19

Our team discusses the digital therapeutics landscape, the opportunities for both biopharma and tech companies, regulatory and payer hurdles, and more.

#20

Kim Johnson, President at GSW, a Syneos Health Company, discusses some the key trends that will impact healthcare advertising, the role of transformative technology, and the core values that drive her and her teams to do good work.

#21

In our increasingly digital world, it was only a matter of time before search and social marketing would start to take on an important role in clinical trial patient recruitment.

#22

10 Cloverfield Lane is one of the movies featured on both Delta and Virgin Atlantic this month – so no surprise that so many Cannes attendees were primed and ready to hear this morning’s McCann Health presentation with Dan Trachtenberg, the film’s director.

#23

In today’s dynamic landscape, life science leaders don’t need more data; they need decision-driving insights to be able to act and invest with confidence.

#24

Syneos Health Communications Drives Public Relations Group with Prominent Hires across Key Growth Offerings

#25

Why do people make good (and bad) decisions about their health?

#26

Neel Patel, Managing Director and Sachin Purwar, Director at Syneos Health Consulting discuss the last ten years of dealmaking and take a look forward based on the results of our 10th annual Dealmakers' Intentions Study.

#27

Since Stanley Kubrick's 2001: A Space Odyssey introduced the prospect of Artificial Intelligence (AI) with the spaceship computer system HAL, the world has had a rollercoaster relationship with the idea - from hope to hype, and everywhere in between.

#28

PIE – or Preapproval Information Exchange – refers to the communication of clinical and health care economic information on therapies in development between U.S. population health decision makers and drug manufacturers prior to regulatory approval.

#29

The biopharmaceutical market has evolved quite a bit over the last five to 10 years.

#30

Curious how the Institute for Clinical and Economic Review works?

Search Results

Connect

Site

Search Results

Connect

Site

Subscribe to our RSS feed